×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VERU – veru inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VERU
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:03 pm
veru
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop [Yahoo! Finance]
Low
Report
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop [Yahoo! Finance]
12/4
08:30 am
veru
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
Medium
Report
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
11/17
02:54 pm
veru
Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight [Yahoo! Finance]
Low
Report
Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight [Yahoo! Finance]
10/31
08:30 am
veru
Veru to Present Two Abstracts at ObesityWeek 2025
Low
Report
Veru to Present Two Abstracts at ObesityWeek 2025
10/30
08:00 am
veru
Veru Announces Pricing of $25 Million Public Offering
Medium
Report
Veru Announces Pricing of $25 Million Public Offering
10/29
04:01 pm
veru
Veru Announces Proposed Public Offering
High
Report
Veru Announces Proposed Public Offering
9/27
08:45 am
veru
Onconetix announces financing through private placement, debt settlement [Yahoo! Finance]
Low
Report
Onconetix announces financing through private placement, debt settlement [Yahoo! Finance]
9/26
08:44 am
veru
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. [Yahoo! Finance]
Medium
Report
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/3
05:25 pm
veru
Form 4 VERU INC. For: Oct 01 Filed by: Rankowitz Michael L
Medium
Report
Form 4 VERU INC. For: Oct 01 Filed by: Rankowitz Michael L
10/3
05:15 pm
veru
Form 4 VERU INC. For: Oct 01 Filed by: Hyun Grace
Medium
Report
Form 4 VERU INC. For: Oct 01 Filed by: Hyun Grace
10/3
05:06 pm
veru
Form 4 VERU INC. For: Oct 01 Filed by: Lu Lucy
Medium
Report
Form 4 VERU INC. For: Oct 01 Filed by: Lu Lucy
9/26
09:00 am
veru
Form 8-K VERU INC. For: Sep 22
Medium
Report
Form 8-K VERU INC. For: Sep 22
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/13
Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds? [Yahoo! Finance News]
25.0%
12/13 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. 12.1%
6/4 Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA 8.8%
1/21 Veru Inc (NASDAQ: VERU) had its "reduce" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.50. 8.8%
2/19 Form 4 VERU INC. For: Feb 19 Filed by: Socorro Jesus 7.8%
9/28 Veru Inc (NASDAQ: VERU) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. 7.5%
8/28 Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York 6.6%
3/4 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 5.1%
5/3 Form 4 VERU INC. For: May 01 Filed by: STEINER MITCHELL SHUSTER 4.1%
11/2 Veru Inc (NASDAQ: VERU) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 4.1%
12/13 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. 12.1%
6/4 Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA 8.8%
1/21 Veru Inc (NASDAQ: VERU) had its "reduce" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.50. 8.8%
2/19 Form 4 VERU INC. For: Feb 19 Filed by: Socorro Jesus 7.8%
9/28 Veru Inc (NASDAQ: VERU) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. 7.5%
8/28 Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York 6.6%
3/4 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 5.1%
5/3 Form 4 VERU INC. For: May 01 Filed by: STEINER MITCHELL SHUSTER 4.1%
11/2 Veru Inc (NASDAQ: VERU) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 4.1%
TOP News Decliners
8/27
Veru to Ring NASDAQ Closing Bell on September 4th to Kick Off National Prostate Cancer Awareness Month
-9.5%
8/8 Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter -9.4%
12/12 Form 8-K VERU INC. For: Dec 12 -7.7%
8/9 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. -7.5%
5/15 Q2/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.050 ActVsEst (0.010) - Miss -7.1%
6/6 Veru Inc (NASDAQ: VERU) was given a new $5.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. -6.3%
8/1 Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th -6.3%
1/28 Form DEF 14A VERU INC. For: Mar 24 -5.4%
1/25 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.4%
1/13 Veru's experimental drug reduces hot flashes in men in mid-stage study [Reuters (UK)] -3.9%
8/8 Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter -9.4%
12/12 Form 8-K VERU INC. For: Dec 12 -7.7%
8/9 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. -7.5%
5/15 Q2/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.050 ActVsEst (0.010) - Miss -7.1%
6/6 Veru Inc (NASDAQ: VERU) was given a new $5.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. -6.3%
8/1 Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th -6.3%
1/28 Form DEF 14A VERU INC. For: Mar 24 -5.4%
1/25 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.4%
1/13 Veru's experimental drug reduces hot flashes in men in mid-stage study [Reuters (UK)] -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: